PT-141 specifically targets receptors in the brain associated with sexual motivation and arousal pathways
It can be easily absorbed into the bloodstream by injections, which can help prevent chronic neurological and cellular damage
The "K" denotes KPV, added to the GLOW base (GHK-Cu, BPC-157, TB-500)
The Precision Peptide Genetic Test reveals predispositions in peptide-related pathways (GIPR, GLP1R, FTO, MC4R variants) but does not predict B12 metabolism directly
Retatrutide adds a third mechanism: glucagon receptor agonism
This powerful combination has the potential to expedite the recovery process and support tissue repair while enhancing athletic performance, among other therapeutic endpoints [5]